Analysis of Short-Term Outcomes in Pancreatic Surgery with Vascular Resection from a Prospective Multicenter Global Study
Pascale Tinguely(Royal Free London NHS Foundation Trust), Nicolás Devaud(Fundación Arturo López Pérez), Thilo Hackert(Universität Hamburg), Martín de Santibañes, Orlando Jorge Martins Torres, Christian Diaz, Aditya Borakati, Mohammad Abu Hilal(Casa di Cura Villa Garda), Ajith K. Siriwardena(Manchester Royal Infirmary), Marc G. Besselink(Amsterdam Neuroscience), Marinos Zachiotis, Sebastian M. Staubli(University of Lausanne), Atsushi Oba(Tokyo Medical and Dental University), Mehrdad Nikfarjam(Austin Health), Martin H. Smith(University of the Witwatersrand), Andreas A. Schnitzbauer(American Institute of Biological Sciences), Giuseppe Fusai(The Royal Free Hospital), Shailesh V. Shrikhande(Homi Bhabha National Institute), Christian E. Oberkofler(Klinik Hirslanden), Ioannis Passas(St Savas Hospital), Dimitri Aristotle Raptis(King Faisal Specialist Hospital & Research Centre), Nikolaos Machairas, Nikolay Belev, Janet Martin, Marco Del Chiaro(University of Colorado Hospital), Deniz Balcı, Massimo Falconi(Vita-Salute San Raffaele University), Gregory Sergeant, Kevin C. Conlon(Trinity College Dublin), Fiammetta Soggiu, Claudio Bassi(University of Verona), Ewen M. Harrison(NHS Lothian), Christopher L. Wolfgang(Johns Hopkins University), Reena Ravikumar, Giovanni Marchegiani, Christos Dervenis(Agia Olga Hospital), Brian Davidson(King Faisal Specialist Hospital & Research Centre), Ephraim Tang, Domenico Tamburrino, Aliaksei Shcherba, Camila Hidalgo Salinas(University of Oxford), Salah Eddine Kacimi, Gustavo Coelho, Kamel Bentabak, Burundi Fabrice, Cristina Ferrone, The Pancreasgroup.org Country Leaders, Patricia Sánchez‐Velázquez(King Faisal Specialist Hospital & Research Centre), The Pancreasgroup.org Chief Investigator, Alice C. Wei(Université Paris Cité)
Cited by 7
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
|Science|2011|1.7k